SCHEMBL5329359

SCHEMBL5329359

NC(CCCCNS(=O)(=O)NC(=O)O)C(=O)Nc1cccc2cccnc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 6/20 0.53
NLN Q9BYT8 1/20 0.50
HTT P42858 1/20 0.45
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HDAC1 Q13547 8/20 0.44
POLB P06746 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
KDR P35968 1/20 0.43
HDAC4 P56524 5/20 0.43
MEF2D Q14814 2/20 0.43
HDAC3 O15379 2/20 0.43
HDAC7 Q8WUI4 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC10 Q969S8 2/20 0.43
HDAC11 Q96DB2 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC9 Q9UKV0 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5464247 0.88 HDAC6 (0.69) HDAC6NLNHTTMEN1MAPT
SCHEMBL5464229 0.88 HDAC6 (0.69) HDAC6NLNHTTMEN1MAPT
SCHEMBL8106567 0.86 HDAC6 (0.48) HDAC6NLNMAPTSMN1; SMN2HDAC1
SCHEMBL8103276 0.86 HDAC6 (0.48) HDAC6NLNMAPTSMN1; SMN2HDAC1
SCHEMBL5322761 0.85 HDAC1 (0.52) HDAC6HTTMEN1MAPTKMT2A
SCHEMBL5455396 0.78 HDAC6 (0.64) HDAC6HDAC1HDAC4MEF2DHDAC3
SCHEMBL5466442 0.77 HDAC1 (0.50) HDAC6MAPTHDAC1HDAC4MEF2D
SCHEMBL14254943 0.76 HDAC1 (0.68) HDAC6NLNHTTHDAC1POLB
SCHEMBL21221222 0.76 HDAC4 (0.59) HDAC6NLNHTTMEN1KMT2A
SCHEMBL5327739 0.76 KDM4E (0.50) HDAC6NLNHTTMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007143822-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-21 WO disclosed
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HAT1 HDAC6 11/4885NLN 4696/4885HTT 711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.